Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE W)

Clinical trial NCT00243178 · TERMINATED

Trial details

NCT number: NCT00243178
Sponsor: Sanofi
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Atrial Fibrillation Vascular Risk

Start date: 2003-07-01
Primary completion: 2005-09-01
Enrollment: 6706

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.